• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-甲基-D-天冬氨酸(NMDA)受体亚基密度的改变以及配体与甘氨酸识别位点的结合与阿尔茨海默病中的慢性焦虑有关。

Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease.

作者信息

Tsang Shirley W Y, Vinters Harry V, Cummings Jeffrey L, Wong Peter T-H, Chen Christopher P L-H, Lai Mitchell K P

机构信息

Dementia Research Laboratory, Department of Clinical Research, Singapore General Hospital, Singapore.

出版信息

Neurobiol Aging. 2008 Oct;29(10):1524-32. doi: 10.1016/j.neurobiolaging.2007.03.014. Epub 2007 Apr 11.

DOI:10.1016/j.neurobiolaging.2007.03.014
PMID:17433503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2667969/
Abstract

Glutamatergic deficits are established neuropathological features of Alzheimer's disease (AD) and are known to correlate with cognitive impairments. In contrast, the role of glutamatergic alterations in behavioral and psychological symptoms of dementia (BPSD) is unclear. There is considerable preclinical evidence for the importance of glycine recognition sites (GlyRS) of N-methyl-D-aspartate (NMDA) receptors in the regulation of anxiety behaviors. This study aimed to correlate several glutamatergic measures with chronic anxiety in AD. Twenty-one AD patients assessed by the Neuropsychiatric Inventory (NPI) were divided into low anxiety (LA) and high anxiety (HA) subgroups. GlyRS and NMDA channel were measured by brain homogenate binding with [(3)H]MDL105,519 and [(3)H]MK-801, respectively. Densities of NMDA receptor NR2A, NR2B and alternate spliced NR1 subunits were quantified by immunoblotting. We found that the binding affinity to GlyRS was significantly higher in HA compared to LA, and this higher GlyRS affinity correlated with selective reduction of NR2A density as well as with elevated anxiety scores. Our observations suggest a novel mechanism whereby subunit specific changes in the NMDA receptor complex may be linked to chronic anxiety in AD via effects on GlyRS function. We propose that NR2A and GlyRS should be further assessed as novel targets of behavioral pharmacotherapy in AD.

摘要

谷氨酸能缺陷是阿尔茨海默病(AD)已确定的神经病理学特征,并且已知与认知障碍相关。相比之下,谷氨酸能改变在痴呆的行为和心理症状(BPSD)中的作用尚不清楚。有大量临床前证据表明N-甲基-D-天冬氨酸(NMDA)受体的甘氨酸识别位点(GlyRS)在调节焦虑行为中具有重要性。本研究旨在将几种谷氨酸能指标与AD中的慢性焦虑相关联。通过神经精神科问卷(NPI)评估的21名AD患者被分为低焦虑(LA)和高焦虑(HA)亚组。分别通过脑匀浆与[(3)H]MDL105,519和[(3)H]MK-801结合来测量GlyRS和NMDA通道。通过免疫印迹法对NMDA受体NR2A、NR2B和可变剪接的NR1亚基的密度进行定量。我们发现,与LA相比,HA对GlyRS的结合亲和力显著更高,并且这种更高的GlyRS亲和力与NR2A密度的选择性降低以及焦虑评分升高相关。我们的观察结果提示了一种新机制,即NMDA受体复合物中亚基特异性变化可能通过对GlyRS功能的影响与AD中的慢性焦虑相关联。我们建议应进一步评估NR2A和GlyRS作为AD行为药物治疗新靶点的可能性。

相似文献

1
Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease.N-甲基-D-天冬氨酸(NMDA)受体亚基密度的改变以及配体与甘氨酸识别位点的结合与阿尔茨海默病中的慢性焦虑有关。
Neurobiol Aging. 2008 Oct;29(10):1524-32. doi: 10.1016/j.neurobiolaging.2007.03.014. Epub 2007 Apr 11.
2
Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.重组 N-甲基-D-天冬氨酸受体上的配体亲和力取决于亚基组成。
Eur J Pharmacol. 1994 Aug 16;268(3):335-45. doi: 10.1016/0922-4106(94)90058-2.
3
N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease.N-甲基-D-天冬氨酸受体亚基蛋白及其磷酸化状态在阿尔茨海默病中发生选择性改变。
J Neurol Sci. 2001 Jan 1;182(2):151-9. doi: 10.1016/s0022-510x(00)00467-6.
4
The integrity of the glycine co-agonist binding site of N-methyl-D-aspartate receptors is a functional quality control checkpoint for cell surface delivery.N-甲基-D-天冬氨酸受体甘氨酸共激动剂结合位点的完整性是细胞表面转运的功能质量控制检查点。
J Biol Chem. 2009 Jan 2;284(1):324-333. doi: 10.1074/jbc.M804023200. Epub 2008 Nov 6.
5
N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease.在阿尔茨海默病患者的海马体和内嗅皮质中,N-甲基-D-天冬氨酸受体亚基NR2A和NR2B的信使核糖核酸水平发生了改变。
J Neurol Sci. 2002 Aug 15;200(1-2):11-8. doi: 10.1016/s0022-510x(02)00087-4.
6
In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.SM-31900对NMDA受体甘氨酸结合位点的体外和体内拮抗活性。
Brain Res. 2002 Jul 19;944(1-2):165-73. doi: 10.1016/s0006-8993(02)02741-5.
7
The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.NMDA受体亚型的分子基础:天然受体多样性由亚基组成预测。
J Neurosci. 1994 Sep;14(9):5471-84. doi: 10.1523/JNEUROSCI.14-09-05471.1994.
8
Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.鉴定和表征新型 NMDA 受体拮抗剂,对 NR2A- 受体亚型选择性高于 NR2B- 受体亚型。
J Pharmacol Exp Ther. 2010 Dec;335(3):636-44. doi: 10.1124/jpet.110.172544. Epub 2010 Sep 1.
9
Evidence for functional native NMDA receptors activated by glycine or D-serine alone in the absence of glutamatergic coagonist.在不存在谷氨酸能协同激动剂的情况下,由甘氨酸或D-丝氨酸单独激活的功能性天然N-甲基-D-天冬氨酸受体的证据。
Eur J Neurosci. 1998 Sep;10(9):2934-44. doi: 10.1046/j.1460-9568.1998.00302.x.
10
N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease.老年人、正常个体及阿尔茨海默病患者海马体中的N-甲基-D-天冬氨酸受体复合物
Neuroscience. 1992 Jul;49(1):45-61. doi: 10.1016/0306-4522(92)90075-d.

引用本文的文献

1
The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's disease.阿尔茨海默病中有效重复经颅磁刺激的神经生物学基础。
Alzheimers Dement. 2025 Jun;21(6):e70337. doi: 10.1002/alz.70337.
2
Non-Genetic Risk Factors of Alzheimer's Disease: An Updated Umbrella Review.阿尔茨海默病的非遗传风险因素:一项最新的综述。
J Prev Alzheimers Dis. 2024;11(4):917-927. doi: 10.14283/jpad.2024.100.
3
Targeting -Methyl-d-Aspartate Receptors in Neurodegenerative Diseases.靶向神经退行性疾病中的 N-甲基-D-天冬氨酸受体。
Int J Mol Sci. 2024 Mar 27;25(7):3733. doi: 10.3390/ijms25073733.
4
Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline.阿尔茨海默病中的焦虑和抑郁:发病机制及与认知衰退关系的系统综述。
Neurol Sci. 2022 Jul;43(7):4107-4124. doi: 10.1007/s10072-022-06068-x. Epub 2022 Apr 23.
5
Emotion Processing Dysfunction in Alzheimer's Disease: An Overview of Behavioral Findings, Systems Neural Correlates, and Underlying Neural Biology.阿尔茨海默病中的情绪加工功能障碍:行为学发现、神经关联系统及潜在神经生物学概述
Am J Alzheimers Dis Other Demen. 2022 Jan-Dec;37:15333175221082834. doi: 10.1177/15333175221082834.
6
Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease (Review).经颅磁刺激对阿尔茨海默病神经生物学变化的影响(综述)。
Mol Med Rep. 2022 Apr;25(4). doi: 10.3892/mmr.2022.12625. Epub 2022 Feb 4.
7
Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach.痴呆神经精神症状的神经药理学和疼痛的作用:佛手柑精油作为一种新的治疗方法。
Int J Mol Sci. 2019 Jul 6;20(13):3327. doi: 10.3390/ijms20133327.
8
The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia.N-甲基-D-天冬氨酸受体神经传递与精准医学在痴呆行为和心理症状中的作用
Front Pharmacol. 2019 May 22;10:540. doi: 10.3389/fphar.2019.00540. eCollection 2019.
9
The Role of miR-150 in Stress-Induced Anxiety-Like Behavior in Mice.miR-150 在应激诱导的小鼠焦虑样行为中的作用。
Neurotox Res. 2019 Jan;35(1):160-172. doi: 10.1007/s12640-018-9943-x. Epub 2018 Aug 17.
10
Network Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimer's Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the Disease.死后脑微阵列的网络拓扑分析鉴定出更多与阿尔茨海默病相关的基因和微小RNA,并指出对抗该疾病的新途径。
PLoS One. 2016 Jan 19;11(1):e0144052. doi: 10.1371/journal.pone.0144052. eCollection 2016.

本文引用的文献

1
Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease.
Neurobiol Aging. 2007 Sep;28(9):1381-7. doi: 10.1016/j.neurobiolaging.2006.06.001. Epub 2006 Jul 7.
2
The chemical biology of clinically tolerated NMDA receptor antagonists.临床耐受性NMDA受体拮抗剂的化学生物学
J Neurochem. 2006 Jun;97(6):1611-26. doi: 10.1111/j.1471-4159.2006.03991.x.
3
Advances in the treatment of anxiety: targeting glutamate.焦虑症治疗的进展:以谷氨酸为靶点。
NeuroRx. 2006 Jan;3(1):57-68. doi: 10.1016/j.nurx.2005.12.005.
4
Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice.N-甲基-D-天冬氨酸(NMDA)受体NR2A亚基的基因失活对小鼠具有抗焦虑和抗抑郁样作用。
Neuropsychopharmacology. 2006 Nov;31(11):2405-14. doi: 10.1038/sj.npp.1301039. Epub 2006 Feb 8.
5
Glutamate in CNS disorders as a target for drug development: an update.中枢神经系统疾病中的谷氨酸作为药物开发靶点:最新进展
Drug News Perspect. 1998 Nov;11(9):523-69. doi: 10.1358/dnp.1998.11.9.863689.
6
Influence of behavioral symptoms on rates of institutionalization for persons with Alzheimer's disease.行为症状对阿尔茨海默病患者机构收容率的影响。
Psychol Med. 2004 Aug;34(6):1129-35. doi: 10.1017/s0033291703001831.
7
Differential expression of N-methyl-D-aspartate receptor NR2 isoforms in Alzheimer's disease.阿尔茨海默病中N-甲基-D-天冬氨酸受体NR2亚型的差异表达
J Neurochem. 2004 Aug;90(4):913-9. doi: 10.1111/j.1471-4159.2004.02548.x.
8
Selective loss of NMDA receptor NR1 subunit isoforms in Alzheimer's disease.
J Neurochem. 2004 Apr;89(1):240-7. doi: 10.1111/j.1471-4159.2003.02330.x.
9
Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer's disease.纹状体D2受体密度降低与阿尔茨海默病严重行为异常相关。
Ann Nucl Med. 2003 Oct;17(7):567-73. doi: 10.1007/BF03006670.
10
Activity-dependent mRNA splicing controls ER export and synaptic delivery of NMDA receptors.依赖活性的mRNA剪接控制NMDA受体的内质网输出和突触传递。
Neuron. 2003 Oct 30;40(3):581-94. doi: 10.1016/s0896-6273(03)00676-7.